Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for ...

Janux Therapeutics, Inc. (Nasdaq: JANX) ("Janux"), a clinical-stage biopharmaceutical company developing a broad pipeline of ...

These photos will blow your mind.

Musculoskeletal aging is a critical area of research that addresses key aspects of health and mobility in the aging ...

The mining giant’s landmark iron ore pricing agreement with Beijing is expected to have far-reaching implications for ...

Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2026. The full report can be ...

Muscular Dystrophy Association Marks ALS Awareness Month throughout May with Breakthrough Research, Powerful Stories, and ...

Oral agent in second-line more than doubled median PFS in patients with ESR1 muta ...

The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.

SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

Stop overlooking the most practical strength test in the fitness world. Learn why simply picking up heavy weights and walking ...